|1.||Chen, Zhuang: 2 articles (08/2003 - 02/2002)|
|2.||Xiang, Jim: 2 articles (08/2003 - 02/2002)|
|3.||Liu, Yongqing: 2 articles (08/2003 - 02/2002)|
|4.||Zhang, Weidong: 2 articles (12/2002 - 02/2002)|
|5.||Huang, Hui: 1 article (08/2003)|
|6.||Zong, Li: 1 article (08/2003)|
|7.||Wang, Zehua: 1 article (12/2002)|
|8.||Yang, Hong: 1 article (12/2002)|
|9.||Jim, Xiang: 1 article (12/2002)|
|10.||Chan, Tim: 1 article (02/2002)|
08/01/2003 - "Vaccinations of Mut1-pulsed DCs, DC(pLpA) and DC(Flt3L) all protected mice from challenge of low dose (0.5 x 10(5)) tumor cells. "
02/01/2002 - "Vaccination of mice with Mut1 peptide-pulsed control virus-transfected DC (DC(pLpA)) could only protect mice from challenge of a low dose (0.5 x 10(5) cells per mouse, 8/8 mice), but not a high dose (3 x 10(5) cells per mouse, 0/8 mice) of 3LL tumor cells. "
02/01/1999 - "In mice bearing large tumors, this treatment also caused significant inhibition of tumor growth with a mean tumor weight of 0.65 g vis-a-vis 3.05 g for tumors injected with the control AdV-pLpA. "
02/01/1999 - "In mice bearing small tumors, intratumoral injection of 2X10(9) pfu of AdV-TNF-alpha virus with a repeated booster treatment resulted in complete regression of three tumors and significant diminution of the other two with a mean tumor-weight of 0.16 g; this is in contrast to 0.85 and 1.62 g for tumors injected with the control AdV-pLpA and PBS respectively (p < 0.01). "
11/01/1998 - "Intratumoral injections of 2 x 10(9) plaque-forming units of pLpA/M4-TNF-alpha virus with a repeated booster resulted in significant VKCK tumor regression in immune-competent mice, but not in athymic nude mice with a mean tumor weight of 0.07 g that were compared with 1.58 g and 1.70 g for tumors injected with AdV5LacZ and phosphate-buffered saline, respectively (P < .01). "
11/01/1998 - "After the in vitro transfection of pLpA/M4-TNF-alpha at a multiplicity of infection of 1000, transfected VKCK cells showed significant secretion of RM4/TNF-alpha (36 ng/mL/10(6) cells) containing the functional TNF-alpha moiety in tissue culture. "
12/01/2002 - "MDCs infected with AdV-TNF-alpha and AdV-pLpA (no gene insert) at 100 multiplicity of infection (MOI) were analyzed by RNase protection assay for their cytokine secretion. "
|3.||Addison Disease (Addison's Disease)
|1.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|2.||Staphylococcal Protein A (A, Protein)